Nanoparticulate systems for oral drug delivery to the colon

International Journal of Nanotechnology

Volumn 8, Issue 1-2, 2011, Pages 4-20

  O'Donnell, Kevin P ^a   Williams III, Robert O ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Colon; Drug delivery; Drug targeting; Gastrointestinal tract; Nanogel; Nanoparticle; Nanoparticles in microspheres; Oral; Surface modification

Indexed keywords

CONTROLLED DRUG DELIVERY; DRUG DELIVERY; NANOPARTICLES; NANOSTRUCTURED MATERIALS; SURFACE TREATMENT;

COLON; DRUG-TARGETING; GASTROINTESTINAL TRACT; NANOGELS; ORAL;

TARGETED DRUG DELIVERY;

EID: 78649701704     PISSN: 14757435     EISSN: None     Source Type: Journal    
DOI: 10.1504/IJNT.2011.037167     Document Type: Article

References (86)

1. Ashford, M. and Fell, J.T. (1994) 'Targeting drugs to the colon: delivery systems for oral administration', J. Drug Targeting, Vol. 2, pp.241-258.
2. Sinha, V.R., Singh, A., Kumar, R.V., Sing, S., Kumria, R. and Bhinge, J.R. (2007) 'Oral colon-specific drug delivery of protein and peptide drugs', Critical Reviews in Therapeutic Drug Carrier Systems, Vol. 24, No. 1, pp.63-92.
3. Kinget, R., Kalala, W., Vervoort, L. and Mooter, G.V. (1998) 'Colon drug targeting', J. Drug Targeting, Vol. 6, No. 2, pp.129-149.
4. Khan, M.Z.I., Prebeg, Z. and Kurjaković, N. (1999) 'A pH-dependent colon targeted drug delivery system using methacrylic acid copolymers: I. Manipulation of drug release using Eudragit L100-55 and Eudragit S100 combinations', J. Controlled Release, Vol. 58, pp.215-222.
5. Wang, J., Xue, H., Liu, X. and Gao, Y. (2008) 'Coating composition and technology research of berberine tablets colon delivery system', Zhongchengyao, Vol. 30, No. 12, pp.1778-1781.
6. Gazzaniga, A., Busetti, C., Moro, L., Sangalli, M.E. and Giordano, F. (1995) 'Time-dependent oral delivery systems for colon targeting', S. T. P. Pharma Sciences, Vol. 5, No. 1, pp.83-88.
7. Ji, C.M., Xu, H.N. and Wu, W. (2009) 'Guar gum as potential film coating material for colon-specific delivery of fluorouracil', J. Biomater. Appl., Vol. 23, No. 4, pp.311-329.
8. McNeil, M.E., Rashid, A. and Stevens, H.N.E. (1994) 'Drug dispensing device', US Patent, Vol. 5, pp.342-624.
9. Stevens, H.N.E., Wilson, C.G., Welling, P.G., Bakhshaee, M., Binns, J.S., Perkins, A.C., Frier, M., Blackshaw, E.P., Frame, M.W., Nichols, D.J., Humphrey, M.J. and Wicks, S.R. (2002) 'Evaluation of Pulsincap™ to provide regional delivery of dofetilide to the human GI tract', Int. J. Pharm., Vol. 236, pp.27-34.
10. Niwa, K., Takaya, T., Morimoto, T. and Takada, K. (1995) 'Preparation and evaluation of a time-controlled release capsule made of ethylcellulose for colon delivery of drugs', J. Drug Targeting, Vol. 3, pp.83-89.
11. Alvarez-Fuentes, J., Fernández-Arévalo, M., González-Rodríguez, M.L., Cirri, M. and Mura, P. (2004) 'Development of enteric-coated timed-release matrix tablets for colon targeting', J. Drug Targeting, Vol. 12, Nos. 9-10, pp.607-612.
12. Krogars, K., Heinämäki, J., Vesalahti, J., Marvola, M., Antkaninen, O. and Yliruusi, J. (2000) 'Extrusion-spheronization of pH-sensitive polymeric matrix pellets for possible colonic drug delivery', Int. J. Pharm., Vol. 199, pp.187-194.
13. Klotz, U. (1985) 'Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid', Clinical Pharmacokinetics, Vol. 10, pp.285-302.
14. Norlander, B., Gotthard, R. and Stroem, M. (1989) 'Pharmacokinetics of a 5-aminosalicylic acid enteric-coated tablet and suppository dosage form', Alimentary Pharmacology and Therapeutics, Vol. 3, No. 4, pp.333-342.
15. Jung, Y.J., Doh, M.J., Kim, I.H., Kong, H.S., Lee, J.S. and Kim, Y.M. (2003) 'Prednisolone 21-sulfate sodium: a colon-specific pro-drug of prednisolone', J. Pharm. Pharmacol., Vol. 55, No. 8, pp.1075-1082.
16. Katsuma, M., Watanabe, S., Kawai, H., Takemura, S., Masuda, Y. and Fukui, M. (2002) 'Studies on lactulose formulations for colon-specific drug delivery', Int. J. Pharm., Vol. 249, pp.33-43.
17. Ruiz, J.F.M., Radics, G., Windle, H., Serra, H.O., Simplício, A.L., Kedziora, K., Fallon, P.G., Kelleher, D.P. and Gilmer, J.F. (2009) 'Design, synthesis, and pharmacological effects of a cyclization-activated steroid prodrug for colon targeting in inflammatory bowel disease', J. Med. Chem., Vol. 52, No. 10, pp.3205-3211.
18. Asghar, L.F.A. and Chandran, S. (2006) 'Multiparticulate formulation approach to colon specific drug delivery: current perspectives', Journal of Pharmacy and Pharmaceutical Science, Vol. 9, No. 3, pp.327-338.
19. Mooter, G.V. (2006) 'Colon drug delivery', Expert Opin. Drug Discovery, Vol. 3, No. 1, pp.111-125.
20. Lipinski, C.A., Lombardo, F., Dominy, B.W. and Feeney, P.J. (2001) 'Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings', Advanced Drug Delivery Reviews, Vol. 46, pp.2-26.
21. Jai, L. (2005) 'Nanoparticle formulation increases oral bioavailability of poorly soluble drugs: approaches, experimental evidences and theory', Current Nanoscience, Vol. 1, No. 3, pp.237-243.
22. Li, H., Zhao, X., Ma, Y., Zhai, G., Li, L. and Lou, H. (2009a) 'Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles', J. Controlled Release, Vol. 133, pp.238-244
23. Li, X., Ding, L., Xu, Y., Wang, Y. and Ping, Q. (2009b) 'Targeted delivery of doxorubicin using stealth liposomes modified with transferrin', Int. J. Pharm., Vol. 373, pp.116-123.
24. Venkatesan, N., Yoshimitsu, J., Ito, Y., Shibata, N. and Takada, K. (2005) 'Liquid filled nanoparticles as a drug delivery tool for protein therapeutics', Biomaterials, Vol. 26, pp.7154-7163.
25. Rieux, A., Fievez, V., Garinot, M., Schneider, Y. and Préat, V. (2006) 'Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach', J. Controlled Release, Vol. 116, pp.1-27.
26. Janovská, L., Vetchý, D. and Rabišková, M. (2006) 'New systems for colonic drug targeting', Ceska a Slovenska Farmacie, Vol. 55, No. 5, pp.203-209.
27. Niu, L., Xu, Y., Dai, Z. and Tang, H. (2008) 'Gene therapy for type 1 diabetes mellitus in rats by gastrointestinal administration for chitosan nanoparticles containing human insulin gene', World Journal of Gastroenterology, Vol. 14, No. 26, pp.4209-4215.
28. Woodley, J.F. (1992) 'Peptidase enzymes of the GI tract: barriers to peptide delivery, but potential for controlled release', Proc. Int. Symp. Controlled Release of Bioactive Material, Vol. 19, pp.2-3.
29. Bhavsar, M.D. and Amiji, M.M. (2008) 'Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease', Gene Ther., Vol. 15, pp.1200-1209.
30. Woitiski, C.B., Carvalho, R.A., Ribeiro, A.J., Neufeld, R.J. and Veiga, F. (2008) 'Strategies toward the improved oral delivery of insulin nanoparticles via gastrointestinal uptake and translocation', Biodrugs, Vol. 22, No. 4, pp.223-237.
31. Bhavsar, M.D., Shenoy, D.B. and Amiji, M.M. (2006) 'Polymeric nanoparticles for delivery in the gastro-intestinal tract', in Torchilin, V.P. (Ed.): Nanoparticulates as Drug Carriers, Imperial College Press, London, pp.609-648.
32. Washington, N., Washington, C. and Wilson, C.G. (2001) 'Physiological pharmaceutics: biological barriers to drug absorption', Wilson, C.G. (Ed.): Taylor & Francis, New York.
33. Lai, S.K., Wang, Y. and Hanes, J. (2009) 'Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues', Adv. Drug Delivery Rev., Vol. 61, pp.158-171.
34. Matsuo, K., Ota, H., Akamatsu, T., Sugiyama, A. and Katsuyama, T. (1997) 'Histochemistry of the surface mucous gel layer of the human colon', Gut, Vol. 40, pp.782-789.
35. Strugala, V., Allen, A., Dettmar, P.W. and Pearson, J.P. (2003) 'Colonic mucin: methods of measuring mucus thickness', Proceedings of the Nutrition Society, Vol. 62, pp.237-243.
36. Thornton, D.J. and Sheehan, J.K. (2004) 'From mucins to mucus', Proceedings of the American Toracic Society, Vol. 1, pp.54-61.
37. Corfield, A.P., Carroll, D., Myerscough, N. and Probert, C.S.J. (2001) 'Mucins in the gastrointestinal tract in health and disease', Frontiers in Bioscience, Vol. 6, pp.d1321-d1357.
38. Szentkuti, L. (1997) 'Light microscopical observations on luminally administered dyes, dextrans, nanospheres and microspheres in the pre-epithelial mucus gel layer of the rat distal colon', J. Controlled Release, Vol. 46, pp.233-242.
39. Atuma, C., Strugala, V., Allen, A. and Holm, L. (2001) 'The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo', The American Journal of Physiology: Gastrointestinal and Liver Physiology, Vol. 280, pp.G922-G929.
40. van der Waaij, L.A., Limburg, P.C., Mesander, G. and van der Waaij, D. (1996) 'In vivo IgA coating of anaerobic bacteria in human faeces', Gut, Vol. 38, No. 3, pp.348-354.
41. Wang, A. and Li, S. (2008) 'Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect', BMC Biotech., Vol. 8, No. 46, pp.1-7.
42. Araujo, L., Sheppard, M., Löbenberg, R. and Kreuter, J. (1999) 'Uptake of PMMA nanoparticles from the gastrointestinal tract after oral administration to rats: modification of the body distribution after suspension in surfactant solutions and in oil vehicles', Int. J. Pharm., Vol. 176, pp.209-224.
43. Volkheimer, G. (1977) 'Persorption of particles: physiology and pharmacology', Advanced Pharmacology and Chemotherapy, Vol. 14, pp.163-187.
44. Harush-Frenkel, O., Rozentur, E., Benita, S. and Altschuler, Y. (2008) 'Surface charge of nanoparticles determines their endocytic and transcytotic pathways in polarized MDCK cells', Biomacromolecules, Vol. 9, No. 2, pp.435-443.
45. Hussain, N., Jaitley, V. and Florence, A. (2001) 'Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics', Adv. Drug Delivery Rev., Vol. 50, pp.107-142.
46. Kreuter, J. (1991) 'Peroral administration of nanoparticles', Adv. Drug Delivery Rev., Vol. 7, pp.71-86.
47. Dembri, A., Montisci, M.J., Gantier, J.C., Chacun, H. and Ponchel, G. (2001) 'Targeting of 3'-Azido 3'-Deoxythymidine (AZT)-loaded poly(isohexylcyanoacrylate) nanospheres to the gastrointestinal mucosa and associated lymphoid tissues', Pharm. Res., Vol. 18, No. 4, pp.467-473.
48. Delie, F. (1998) 'Evaluation of nano and microparticle uptake by the gastrointestinal tract', Advanced Drug Delivery Reviews, Vol. 34, pp.221-233.
49. Yeh, P., Ellens, H. and Smith, P.L. (1998) 'Physiological considerations in the design of particulate dosage forms for oral vaccine delivery', Adv. Drug Delivery Rev., Vol. 34, pp.123-133.
50. Borchard, G., Luessen, H.L., de Boer, A.G., Verhoef, J.C., Lehr, C.M. and Junginger, H.E. (1996) 'The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro', J. Controlled Release, Vol. 39, pp.131-138.
51. Thanou, M., Verhoef, J.C. and Junginger, H.E. (2001) 'Chitosan and its derivatives as intestinal absorption enhancers', Adv. Drug Delivery Rev., Vol. 50, pp.S91-S101. (Pubitemid 32905357)
52. Bhardwaj, V. and Ravi Kumar, M.N.V. (2007) 'Oral drug delivery', in Domb, A.J., Tabata, Y., Ravi Kumar, M.N.V. and Farber, S. (Eds.): Nanoparticles for Pharmaceutical Applications, American Scientific Publishers, pp.273-286.
53. Lin, Y., Chen, C., Liang, H., Kulkarni, A.R., Lee, P., Chen, C. and Sung, H. (2007) 'Novel nanoparticles for oral insulin delivery via the paracellular pathway', Nanotechnology, Vol. 18, pp.1-11.
54. Emerich, D.F. and Thanos, C.G. (2007) 'Targeted nanoparticle-based drug delivery and diagnosis', J. Drug Targeting, Vol. 15, No. 3, pp.163-183.
55. Lamprecht, A., Ubrich, N., Yamamoto, H., Schäfer, U., Takeuchi, H., Maincent, P., Kawashima, Y. and Lehr, C.M. (2001b) 'Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease', J. Pharmacol. Exp. Ther., Vol. 299, No. 2, pp.775-781.
56. Lamprecht, A., Schäfer, U. and Lehr, C. (2001a) 'Size-dependent bioadhesion of micro and nanoparticlulate carriers to the inflamed colonic mucosa', Pharm. Res., Vol. 18, No. 6, pp.788-793.
57. Pertuit, D., Moulari, B., Betz, T., Nadaradjane, A., Neumann, D., Ismalili, L., Refouvelet, B., Pellequer, Y. and Lamprecht, A. (2007) '5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease', J. Controlled Release, Vol. 123, pp.211-218.
58. Balfour Sartor, R. (2008) 'Microbial influences in inflammatory bowel disease', Gastroenterology, Vol. 134, No. 2, pp.577-594.
59. Finn, W.F. (1999) 'FK506 Nephrotoxicity', Renal Failure, Vol. 21, Nos. 3-4, pp.319-329.
60. Meissner, Y., Pellequer, Y. and Lamprecht, A. (2006) 'Nanoparticles in inflammatory bowel disease: particle targeting versus pH-sensitive delivery', Int. J. Pharm., Vol. 316, pp.138-143.
61. Samstein, R.M., Perica, K., Balderrama, F., Look, M. and Fahmy, T.M. (2008) 'The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles', Biomaterials, Vol. 29, pp.703-708.
62. Lamprecht, A., Yamamoto, H., Takeuchi, H. and Kawashima, Y. (2005) 'A pH-sensitive microsphere system for the colon delivery of tacrolimus containing nanoparticles', J. Controlled Release, Vol. 104, pp.337-346.
63. Lemarchand, C., Gref, R. and Couvreur, P. (2004) 'Polysaccharide- decorated nanoparticles', Eur. J. Pharm. Biopharm., Vol. 58, pp.327-341.
64. Salman, H.H., Gamazo, C., Agüeros, M. and Irache, J.M. (2007) 'Bioadhesive capacity and immunoadjuvant properties of thiamine-coated nanoparticles', Vaccine, Vol. 25, pp.8123-8132.
65. Win, K.Y. and Feng, S.S. (2005) 'Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs', Biomaterials, Vol. 26, pp.2713-2722.
66. Feng, S., Mei, L., Anitha, P., Gan, C.W. and Zhou, W. (2009) 'Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of docetaxel', Biomaterials, Vol. 30, pp.3297-3306.
67. Nakamura, K., Takayama, K., Nagai, T. and Maitani, Y. (2003) 'Regional intestinal absorption of FITC-Dextran 4,400 with nanoparticles based on β-Sitosterol β-D-Glucoside in rats', J. Pharm. Sci., Vol. 92, No. 2, pp.311-318.
68. Vail, D.M., Chun, R., Thamm, D.H., Garrett, L.D., Cooley, A.J. and Obradovich, J.E. (1998) 'Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated (stealth) liposomes: a randomized, double-blind clinical trial using a canine model', Clinical Cancer Research, Vol. 4, pp.1567-1571.
69. Immordino, M.L., Dosio, F. and Cattel, L. (2006) 'Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential', Int. J. Nanomed., Vol. 1, No. 3, pp.297-315.
70. Allen, L.H. and Aderem, A. (1996) 'Mechanisms of phagocytosis', Curr. Opin. in Immun., Vol. 8, pp.36-40.
71. Brown, E.J. (1994) 'Phagocytosis', BioEssays, Vol. 17, pp.109-117.
72. Garg, A., Tisdale, A.W., Haidari, E. and Kokkoli, E. (2008) 'Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide', Int. J. Pharm., Vol. 366, pp.201-210.
73. Jain, A. and Jain, S. (2008) 'In vitro and cell uptake studies for targeting ligand anchored nanoparticles for colon tumors', Eur. J. Pharm. Sci., Vol. 35, pp.404-416.
74. Luppi, B., Bigucci, F., Cerchiara, T., Mandrioli, R., Pietra, A.M.D. and Zecchi, V. (2008) 'New environmental sensitive system for colon-specific delivery of peptidic drugs', Int. J. Pharm., Vol. 358, pp.44-49.
75. Moulari, B., Pertuit, D., Pelleque, Y. and Lamprecht, A. (2008) 'The targeting of surface modified silica nanoparticles to inflamed tissue in experimental colitis', Biomaterials, Vol. 29, pp.4554-4560.
76. Harush-Frenkel, O., Rozentur, E., Benita, S. and Altschuler, Y. (2008) 'Surface charge of nanoparticles determines their endocytic and transcytotic pathways in polarized MDCK cells', Biomacromolecules, Vol. 9, No. 2, pp.435-443.
77. Elzatahry, A.A. and Eldin, M.S.M. (2008) 'Preparation and characterization of metronidazoleloaded chitosan nanoparticles for drug delivery application', Polym. Adv. Technol., Vol. 19, pp.1787-1791.
78. Janes, K.A., Fresneau, M.P., Marazuela, A., Fabra, A. and Alonso, M.J. (2001) 'Chitosan nanoparticles as delivery systems for doxorubicin', J. Controlled Release, Vol. 73, pp.255-267.
79. Curti, E., Britto, D. and Campana-Filho, S.P. (2003) 'Methylation of chitosan with iodomethane: effect of reaction conditions on chemoselectivity and degree of substitution', Macromol. Biosci., Vol. 3, pp.571-576.
80. Bayat, A., Dorkoosh, F.A., Dehpour, A.R., Moezi, L., Larijani, B., Junginger, H.E. and Rafiee-Tehrani, M. (2008) 'Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies', Int. J. Pharm., Vol. 356, pp.259-266.
81. Doherty, E.A.S., Kan, C., Paegel, B.M., Yeung, S.H.I., Cao, S., Mathies, R.A. and Barron, A.E. (2004) 'Sparsely cross-linked 'nanogel' matrixes as fluid, mechanically stabilized polymer networks for High-throughput microchannel DNA sequencing', Anal. Chem., Vol. 76, pp.5249-5256.
82. Yan, M., Liu, Z., Lu, D. and Liu, Z. (2007) 'Fabrication of single carbonic anhydrase nanogel against denaturation and aggregation at high temperature', Biomacromolecules, Vol. 8, pp.560-565.
83. Chang, C., Wang, Z., Quan, C., Cheng, H., Cheng, S., Zhang, X. and Zhuo, R. (2007) 'Fabrication of a novel pH-sensitive glutaraldehyde cross-linked pectin nanogel for drug delivery', J. Biomater. Sci., Polym. Ed., Vol. 18, No. 12, pp.1591-1599.
84. Ray, D., Mohapatra, D.K., Mohapatra, R.K., Mohanta, G.P. and Sahoo, R.K. (2008) 'Synthesis and colon-specific drug delivery of a poly(acrylic acid-co-acrylamide)/MBA nanosized hydrogel', J. Biomater. Sci., Polym. Ed., Vol. 19, No. 11, pp.1487-1502.
85. Ichikawa, H., Fukumori, Y. and Kamiya, H. (2006) 'Functional stimuli-responsive nanogel-particles for oral peptide delivery: preparation, drug-release behaviors and in vitro cellular interaction', NSTI-Nanotechnology, Vol. 2, pp.392-395.
86. Siadat, S.O.R., Mahkam, M. and Mohammadi, R. (2007) 'Double walled polymeric drug delivery systems containing nanoparticle drug intended for colon-specific delivery', Asian J. Chem., Vol. 19, No. 3, pp.1875-1882.